The approval of semaglutide marked a significant advancement in the pharmacological approach to managing obesity and diabetes, two of the most pressing public health concerns of our time
Designed by physicians and rooted in evidence-based care, our approach helps patients achieve real, lasting results, even when other diets and plans have failed
Formulation : Pharmaceutical preparations, including ingredients, to help deliver the drug into the human body
Participants in all studies received semaglutide or placebo in conjunction with structured lifestyle interventions, including caloric restriction and increased physical activity
Diabetes Care, 42 (5), 731754
Other pharmaceutical companies are pouring in, with Amgen, AstraZeneca and Boehringer Ingelheim all working on more potent incretin drugs, including some tablets rather than injectables